Humanin Dosage & Reconstitution Guide
Research and educational use only — not medical advice, and not for human consumption. The figures below are summarized from public sources, product labeling, and community reports, and are not a prescription or a substitute for a qualified clinician.
Dosing schedule
The table below reports the doses used in the underlying research or by the community — it is documentation, not a recommendation to replicate at home.
| Phase | Dose | Notes |
|---|---|---|
| Research doses | 1 mg | fixed ~1–5 mg (native) or ~0.5–2 mg (potent HNG analog) — not weight-scaled |
Timing & cycling
Animal studies used weight-scaled injection; the potent HNG analog is favored in the lab. No human schedule exists.
Cycle length. None established.
Storage & handling
Keep the lyophilized (unmixed) vial refrigerated at 2–8 °C (36–46 °F) in a dry, dark place — it tolerates short periods at room temperature during shipping. Once reconstituted, store it at 2–8 °C, never frozen, and use it within about 2–4 weeks (sooner if the solution turns cloudy or discolored). Swab the stopper before every draw and use a fresh needle each time.
Key points
- A mitochondrial-derived peptide studied for cytoprotection and metabolic effects, mostly in animals and cell lines.
- The 'HNG' derivative you may see sold is far more potent than native humanin — a reason for more caution, not less.
What to monitor
No home markers for its mitochondrial/metabolic endpoints.
Legal & prescription status
No legal prescription exists. It is an unapproved research chemical, sold only for laboratory research and labelled 'not for human consumption.' It is not FDA-approved for any human use.
References
This guide is for research and educational purposes only. It is not medical advice and does not describe a product approved for human use. Always consult a qualified healthcare professional before considering any peptide protocol.